Accès libre

Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans

À propos de cet article

Citez

Association between the rs28366003 (MT2A -5A/G) single nucleotide polymorphism and human diseases

Authors and year of publication (reference No.) Ethnicity n Study participants Sample type Findings
Shokrzadeh et al., 2019 (101) Iranian 95 Men and women with gastric cancer Leukocytes SNP MT2A -5A/G increase the risk of gastric
90 Control healthy men and women adenocarcinoma

Bialkowska et al., 2018 (88) 197 Men with prostate cancer Whole blood No association was found between SNP MT2A -5A/
197 Control men without prostate cancer G and prostate cancer

Liu et al., 2017 (100) Chinese 459 Women with breast cancer Whole blood SNP MT2A -5A/G was associated with different
549 Control healthy women types of breast cancer

130 Men and women with AMD AG genotype subjects had 5.5-fold higher risk for
Garcia et al., 2017 (97) Spanish 96 Control healthy men and women Whole blood AMD; G allele was associated with dry form of AMD

Raudenska et al., 2017 (103) 70 Men and women with type 2 diabetes mellitus No association was found between SNP MT2A -5A/
80 Control healthy men and women G and type 2 diabetes mellitus

165 Men and women with DM
Hattori et al., 2016 (95) Japanese 417 Men and women with CKD Serum GG genotype associated with CKD and AG genotype with DM; no association of MT2A -5A/G and HT
2192 Healthy men and women

130 Men and women with SIP SNP MT2A -5A/G was related to SIP (Schneiderian
Starska et al., 2015 (80) 418 Control men and women without head or neck tumour papilloma); G allele increased 7.7-fold occurrence of SIP (Schneiderian papilloma); SNP MT2A -5A/G was associated with SIP phenotype
Polish 117 Men and women with SIP Tissue of nasal cavities or Heterozygotes vs. homozygotes had increased risk
Starska et al., 2015 (84) 132 Control men and women with normal sinonasal mucosa paranasal sinuses of SIP
323 Men and women with laryngeal cancer AG genotype subjects had 1.6-fold higher risk for
Starska et al., 2014 (81) 418 Control healthy men and women laryngeal cancer development; Association between SNP MT2A -5A/G and tumour aggressiveness

Kizeslak et al., 2014 (82) 534 Women with ductal breast cancer SNP MT2A -5A/G was associated with ductal breast
Polish 556 Control healthy women Whole blood cancer

Kiześlak et al., 2013 (86) Polish 412 Men with prostate cancer AG genotype had higher risk for occurrence of
67 Control men without prostate cancer prostate cancer

Forma et al., 2012 (87) Polish 358 Men with prostate cancer Prostate tissue SNP MT2A -5A/G was associated with prostate
406 Control men without prostate cancer cancer and Gleason score

Kayaalty et al., 2011 (92) Turkish 354 Healthy men and women Whole blood SNPMT24 -5A/G was associated with longevity

Hayashi et al., 2006 (96) Japanese 37 Patients with SALS Whole blood No association between SNP MT2A -5A/G and
206 Control healthy men and women SALS and progression rate

Association between the rs28366003 (MT2A -5A/G) single nucleotide polymorphism and element concentrations in humans

Authors and year of publication (reference No.) MT2A genotype
Ethnicity n Study participants Sample type AA AG GG Findings
As concentrations (μg/g creatine)
Stajnko et al., 2019 (99) Croatian 136 Pregnant women Urine 3.07* 4.58* No differences between genotypes

Gonzalez-et al., 2018 Martinez, (102) Colombian 101 Men and women Urine (Not available) No and association SNP MT2between A -5A/G As

Cd concentrations (μg/L* or μg/kg)

Maternal blood 0.87±0.99* 0.73±0.60*
Sekovanić et al., Croatian 268 Mother-newborn pairs Cord blood 0.06±0.03* 0.05±0.03* No difference in either
2018(4) Placenta 10.1±5.1 8.80±3.70§ sample between genotypes

Hattori et al., 2016 (95) Japanese 2774 Men and women Serum (Graphical illustration: Cd = 0.001*) No differences between genotypes

Adams et al, 2015 (104) US 321 Men and women Urine (Graphical illustration) ↓Cd in urine of G allele carriers

Starska et al., 2015 (84) Polish 117 Men and women with SIP 116±79 376±126 393 AG vs. AA genotype ↑Cd in SIP samples; no association between Cd and SNP MI2A -5A/G in control samples
132 Control men and women with normal sinonasal mucosa Tissue of nasal or paranasal sinuses (dry) 62.2±41.2 96.2±57.1 -

323 Men and women with SCC 198±87 369±128 509±57 AG vs. AA genotype ↑Cd in
Starska et al., 2014 (85) Polish 116 Control men and women with normal laryngeal mucosa Tissue of laryngeal mucosa (dry) 87.2±32.2 113±26 117 both sample types; GG vs. AA and AG vs. GG genotype ↑Cd in SCC samples

Krzeslak et al., 2013 (86) Polish 412 Men with prostate cancer Prostate tissue (dry) 720±330 970±460 1090±220 AG vs. AA genotype ↑Cd in both sample types; GG vs. AA genotype ↑Cd in prostate cancer samples

Tekin et al, 2012 Maternal blood 1.60±0.94* 2.54±2.72* AG vs. AA genotype |Cd in
Turkish 95 Mother-newborn pairs Cord blood 0.95±0.32* 0.98±0.28* maternal blood and ↓Cd in
Placenta 20.8±19.7 8.65±6.70 placenta

Kayaalti et al, 2011 (91) Turkish 616 Men and women Whole blood 1.60±1.44* 2.09±1.85* 5.98±4.38* G allele carriers ↑Cd

Kayaalti et al, 2010 (94) Turkish 114 Men and women Kidney samples (dry) 87.7±62.9† 151±60† 153f ↑Cd in G allele carriers

Pb concentrations (μg/L*or μg/kg)

Maternal blood 13.7±6.6* 12.0±3.6*
Sekovanić et al., 2018(4) Croatian 268 Mother-newborn pairs Cord blood 8.3±5.5* 7.1±4.0*-s No difference in either sample between genotypes
Placenta 6.9±4.9 5.5±2.8§

Yang et al, 2017 (105) Thai 677 Men and women Whole blood 122±122* 105±113* - No differences between genotype

Maternal blood 3.53±1.43* 5.13±2.79* -
Tekin et al, 2012 (901 Turkish 91 Mother-newborn pairs Cord blood 2.42±1.00* 2.94±1.49* - AG vs. AA genotype ↑ Pb in maternal blood
Placenta 7.79±2.55 9.75±4.14 -

Krzeslaketal, 2013 (86) 412 Men with prostate cancer 3.11±1.27† 4.66±1.82† 5.11±2.52† GG vs. AA genotype ↑Pb in
Polish 67 Control men without prostate cancer Prostate tissue (dry) 1.67±0.61f 1.72±0.67f - prostate cancer

Kayaalti et al, 2011 (91) Turkish 616 Men and women Plasma 30.1±13.9* 32.9±14.9* 50.4±11.5* G allele carriers ↑Pb

Hg concentrations (μg/L*or μg/kg)

Maternal blood 13.7±6.6* 12.0±3.6*s
Sekovanić et al., 2018(4) Croatian 268 Mother-newborn pairs Cord blood 8.3±5.5* 7.1±4.0* No difference in either sample between genotypes
Placenta 6.9±4.9 5.5±2.8§

Wang et al., 2012 TTC 239 Men and women Urine 1.03* 0.76* 0.34* No difference between
(106) 247 Men and women Hair 440 390 430 genotypes

Fe concentrations (mg/L*or mg kg-1)

Maternal blood 422±61* 418±56*
Sekovanić et al., 2018(4) Croatian 268 Mother-newborn pairs Cord blood 552±61* 539±57*,§ G allele carriers (AG+GG) vs. AA genotype ↓Fe in placenta
Placenta 83±22 74±18§

Maternal blood 343±89* 373±103* -
Tekin et al, 2012 Turkish 95 Mother-newborn pairs Cord blood 271±130* 456±214* - AG vs. AA genotype ↑Fe in cord blood
Placenta 527±194 624±162 -

Zn concentrations (mg/L*or mg kg-1)

Maternal blood 5.58±0.92* 5.51±0.82*
Sekovanić et al., 2018(4) Croatian 268 Mother-newborn pairs Cord blood 2.78±0.46* 2.58±0.53* No difference in either sample between genotypes
Placenta 13.7±3.0 13.4±1.8§

70 Men and women with diabetics (Graphical illustration: Zn= 3* in AG vs. ~ 7.5* in AA) AG vs. AA genotype ↓Zn in blood in diabetics
Raudenskaet al., 2017(103) Czech 80 Control healthy men and women Whole blood (Graphical illustration: Zn= 5* in AG vs. ~ 6* in AA) no association between Zn and SNP MT2A -5A/G in the control samples

Hattori et al., 2016 (95) Japanese 2774 Men and women Serum (Graphical illustration: Zn = 0.850*) No differences between genotypes

Adams et al, 2015 (104) US 321 Men and women Urine (Graphical illustration) ↓Zn in urine of G allele carriers

117 Men and women with SIP Tissue of nasal cavities or paranasal sinuses (dry) 52.2±41.2 127±76 136 AG vs. AA genotype ↑Zn in SIP tissue samples;
Starska et al., 2015 (84) Polish 132 Control men and women with normal sinonasal mucosa 199±44 204±52 - No association between Zn and SNPMT24 -5A/G in control samples

323 Men and women with SCC 86.4±38.1 184±57 194±74 AG vs. AA genotype ↑Zn in
Starska et al., 2014 (85) Polish 116 Control men and women with normal laryngeal mucosa Tissue of laryngeal mucosa 97.6±30.0 133±27 129 both sample types; GG vs. AA genotype ↑Zn in SCC samples

Krzeslak et al., 2013 (86) 412 Men with prostate cancer 135±48 239±80 243.7±64.4 AG vs. AA genotype ↑Zn in both sample types; GG vs.
Polish 67 Control men without prostate cancer Prostate tissue (dry) 485±119 927±317 AA genotype |Zn in cancer samples

Maternal blood 4.33±1.13* 4.82±1.44* -
Tekin et al, 2012 (89) Turkish 95 Mother- newborn pairs Cord blood 1.32±0.55* 1.48±0.53* - No difference between genotypes
Placenta 50.5±10.1 46.1±7 -

Kayaaltietal,2011(91) Turkish 616 Men and women Plasma 1.01±0.48* 0.84±0.50* 0.39±0.33* G allele carriers ↓Zn

Kayaalti et al., 2010 (94) Turkish 114 Men and women Kidney tissue (dry) 180.2±84.6 192±115 142 No difference between genotypes

Cu concentrations (mg/L*or mg kg-1)

Maternal blood 1.52±0.30* 1.53±0.09*§
Sekovanić et al., 2018(4) Croatian 268 Mother-newborn pairs Cord blood 0.59±0.09* 0.58± 0.12* No difference in either sample between genotypes
Placenta 0.78±0.18 0.74± 0.08§

Adams et al, 2015 (104) US 321 Men and women Urine ( Graphical illustration) ↓Cu in urine of G allele carriers

117 Men and women with SIP Tissue of nasal cavities or paranasal sinuses (dry) 24.2±13.6 27.1±11.6 26.2 No differences between
Starska et al., 2015 (84) Polish 132 Control men and women with normal sinonasal mucosa 11.0±2.98 17.2±5.2 - genotypes in SIP tissue samples; AG vs. AA genotype ↑Cu in control samples

323 Men and women with SCC 14.4±7.83 26.6±12.5 29.7±0.72 AG vs. AA genotype |Cu in
Starska et al., 2014 (85) Polish 116 Control men and women with normal laryngeal mucosa Tissue of laryngeal mucosa 9.85±4.10 12.7±3.56 11.5 both sample types; GG vs. AA genotype |Cu in SCC samples

412 Men with prostate cancer 10.3±4.2 21.1±9.6 25.6±5.8 AG vs. AA genotype
Krzeslak et al., 2013 (86) Polish 67 Control men without prostate cancer Prostate tissue (dry) 2.9±1.3 7.6±2.9 - ↑Cu in both sample types; GG vs. AA genotype ↑ Cu in cancer samples

Maternal blood 1.67±0.34* 1.84±0.50* -
Tekin (89) et al, 2012 Turkish 95 Mother-newborn pairs Cord blood 0.69±0.25* 0.69±0.28* - No difference genotypes between
Placenta 5.90±2.59 6.63±1.73 -

Kayaalti et al., 2011 (91) Turkish 616 Men and women Plasma 1.04±0.44* 1.02±0.52* 0.91±0.37* No difference genotypes between

Kayaalti et al., 2010(94) Turkish 114 Men and women Kidney tissue (dry) 17.2±16.9 15.3±10.6 31.9 No difference genotypes between

Genotype frequencies of the rs10636 (MT2A +838G/C) single nucleotide polymorphism in humans

Authors and year of publication (reference No.) Ethnicity n Study participants Genotype frequencies (%)
GG GC CC
Yang et al., 2017 (105) Thai 677 Men and women 52.4 41.6 6.0

Liu et al., 2017 (100) Chinese 459 Women with breast cancer 52.5 37.5 11.8
549 Control healthy women 52.8 40.8 6.4

García et al., 2017 Spanish 130 Men and women with AMD 56.9 36.9 6.2
(97) 96 Control healthy men and women 67.7 27.1 5.2

Fernandes (119) et al., 2016 Brazilian 221 Workers in car battery factories 62.0 32.0 6.0

Adams et al., 2015 US 170 Premenopausal women 54.0 42.0 4.0
(104) 151 Men and women 62.0 34.0 4.0

130 Men and women with SIP 44.6 43.1 12.3
Starska et al., 2015 (80) Polish 418 Control men and women without head and neck tumours 50.9 41.2 7.9

Starska et al., 2014 Polish 323 Men and women with laryngeal cancer 45.8 46.1 8.1
(81) 418 Control volunteers (men and women) 50.9 41.2 7.9

Yang et al., 2014 Chinese 287 Men and women with CHD 46.0 45.3 8.7
(117) 226 Control healthy men and women 57.1 36.7 6.2

Krześlak et al., 2014 534 Women with breast cancer 57.1 38.4 4.5
(82) Polish 556 Control healthy women 50.3 45.5 4.2

Woods et al., 2013 163 Boys average age 10 years 61.3 30.7 8.0
(116) Portuguese 167 Girls average age 10 years 59.9 33.5 6.6

Chen et al., 2012 (118) Chinese 465 Men and women 52.3 39.5 8.2

Wang et al., 2012 (106) US 464 Men and women 54.1 36.8 9.1

Forma et al., 2012 Polish 358 Men with prostate cancer 48.9 43.3 7.8
(87) 406 Control men without prostate cancer 52.0 40.0 8.0

Gundacker 2009 (120) et al., Austrian 180 Men and women 58.4 33.3 8.3

Yang et al., 2008 Chinese 182 Men and women with DM 46.7 42.9 10.4
(115) 196 Control volunteers (men and women) 42.9 47.4 9.70

100 CS patients 73.0 22.0 5.0
Giacconi et al., 2007 (113) Italian 188 CS patients without cerebrovascular episodes 66.0 30.0 4.0
218 Control elderly volunteers 56.0 37.0 7.0

Association between the rs1610216 SNP (MT2A -209A/G) single nucleotide polymorphism and human diseases

Authors and year of publication (reference No.) Ethnicity n Study participants Sample type Findings
130 Men and women with SIP Tissue of nasal cavities or No association between SNP MT2A
Starska et al., 2015 (80) Polish 418 Control men and women without head and neck tumours paranasal sinuses -209A/G and SIP

323 Men and women with laryngeal cancer Tissue of squamous cell No association between SNPMT24
Starska et al., 2014(81) 418 Control volunteers (men and women) laryngeal cancer -209A/G and development of laryngeal cancer

Krzeslak et al., 2014(82) Polish 534 Women with breast cancer Whole blood No associations between SNP MT2A
556 Control healthy women -209A/G and breast cancer

Forma et al, 2012 (87) Polish 358 Men with prostate cancer Whole blood No association between SNPMT24
406 Control men without prostate cancer -209 A/G and prostate cancer

142 Patients with CAD Positive association between G allele carriers
Kozarova et al., 2012 Bulgarian 101 Patients with DM Leukocytes and DM;
(114) 61 Control healthy volunteers No association between SNF MT2A -209 A/G and CAD

100 CS patients
Giacconi et al., 2007 (113) Italian 188 CS patients without cerebrovascular episodes Blood No association between SNPMT24 -209 A/G and CS or cerebrovascular episodes
218 Control elderly volunteers

Giacconi et al., 2005 (112) Italian 91 Men and women with carotid stenosis Whole blood No association between SNF MT2A -209A/G and hypertension; higher risk of
188 Control elderly men and women ischaemic cardiomyopathy and hyperglycaemia in AA genotype subjects

Genotype frequencies of the rs1610216 (MT2A −209A/G) single nucleotide polymorphism in humans

Authors and year of publication (reference No.) Genotype frequencies (%)
Ethnicity n Study population AA AG GG
Starska et al., 2015 130 Men and women with SIP 73.8 25.4 0.8
(80) Polish 418 Control men and women without head and neck tumours 73.9 25.3 0.8

Starska et al., 2014 Polish 323 Men and women with laryngeal cancer 73.4 26.0 0.6
(81) 418 Control healthy men and women 73.9 25.3 0.8

Krześlak et al., Polish 534 Women with breast cancer 76.4 23.4 0.2
2014 (82) 556 Control healthy women 72.3 27.5 0.2

Forma et al., 2012 Polish 358 Men with prostate cancer 71.8 27.6 0.6
(87) 406 Control men without prostate cancer 72.0 27.8 0.2

142 Patients with CAD 89.2 9.4 1.4
Kozarova 2012 (114et ) al., Bulgarian 101 Patients with DM 69.7 28.3 2.0

61 Control healthy volunteers 90.5 0.0 9.5
100 CS patients 75.0 24.0 1.0

Giacconi et al., 2007 (113) Italian 188 CS patients without cerebrovascular episodes 73.0 25.0 2.0
218 Control elderly volunteers 71.0 26.0 3.0

Giacconi et al., Italian 91 Men and women with carotid stenosis 86.0 14.0 0.0
2005 (112) 188 Control elderly men and women 70.2 26.1 3.7

Association between the rs1610216 (MT2A -209A/G) single nucleotide polymorphism and element concentrations in humans

Authors and year of publication (reference No.) MT2A genotype
Ethnicity n Study participants Sample type AA AG GG Findings

Zn concentrations (mg/L)
Giacconi et al., 2005 (112) Italian 91 Patients: elderly men and women with type 2 diabetes and carotid stenosis Plasma 0.77±0.15 0.88±0.18 ↓Zn in AA vs. AG+GG in patients; in AA genotype subjects ↓Zn in patients 188 Control: healthy elderly men and vs. control
188 Control: healthy elderly men and vs. control women 0.87±0.25 0.88±0.15

Association between the rs10636 (MT2A +838G/C) single nucleotide polymorphism and human diseases

Authors and year of publication (reference No.) Ethnicity n Study participants Sample type Findings
Liu et al., 2017 (100) Chinese 459 Women with breast cancer Whole blood SNPMT2A +838 G/C was associated with breast cancer

549 Control healthy women

Garcia et al., 2017 (97) Spanish 130 Men and women with AMD Whole blood No association between SNPMT2A +838 G/C and AMD

96 Control healthy men and women

Starska et al., 2015 (80) Polish 130 Men and women with SIP Tissue of nasal cavities or paranasal sinuses No association between SNP MT2A +838G/C and SIP

418 Control men and women without head and neck tumours

Starska et al., 2014 (81) Polish 323 Men and women with laryngeal cancer Tissue of squamous cell No association between SNP MT2A +838G/C

418 Control heathy men and women laryngeal cancer and development of laryngeal cancer

Yang et al., 2014 (117) Chinese 287 Men and women with CHD Blood leukocytes SNPMT2A +838G/C was associated with CHD

226 Control healthy men and women

Krzeslak et al., 2014 (82) Polish 534 Women with breast cancer Whole blood No associations between SNPMT24 +838G/C and breast cancer

556 Control healthy women

Yang et al., 2008 (115) Chinese 397 Men and women with DM Whole blood SNPMT24 +838G/C was associated with higher risk for hyperlipidemia and incidence of DM with neuropathy

454 Control men and women

Giacconi et al., 2007 (113) Italian 100 CS patients Blood SNPMT24 +838G/C promote the progression of carotid artery disease to CS

188 CS patients without cerebrovascular episodes

218 Control elderly volunteers

Genotype frequencies of the rs28366003 (MT2A −5A/G) single nucleotide polymorphism in humans

Authors and year of publication (reference No.) Genotype frequencies (%)
Ethnicity n Study participants AA AG GG
Stajnko et al., 2019 (99) Croatian 136 Pregnant women 93.0# 7.0$
Slovenian 176 Non-pregnant women 95.0# 5.0$

Shokrzadeh et al., 2019 (101) Iranian 95 Men and women with gastric cancer 46.4 41.0 12.6
90 Control healthy men and women 57.8 37.8 4.4

Sekovanić et al., 2018 (4) Croatian 268 Mother-newborn pairs 94.0 6.0 §

González-al., 2018 (Martínez 102) et Colombian 101 Men and women 53.4 43.6 3.0

Białkowska et al., 2018 Polish 197 Men with prostate cancer 90.9 9.1§
(88) 197 Control men without prostate cancer 89.3 10.7§

Yang et al., 2017 (105) Thai 677 Men and women 79.5 20.5 0.0

Liu et al., 2017 (100) Chinese 459 Women with breast cancer (various types) 82.3 15.3 2.4
549 Control healthy women 92.5 7.5 0.0

130 Men and women with AMD 88.5 11.5 0.0
García et al., 2017 (97) Spanish 96 Control healthy men and women 97.9 2.1 0.0

Raudenska et al., 2017 (103) 70 Men and women with type 2 diabetes mellitus 88.6 8.6 0.0
Czech 80 Control healthy men and women 86.3 13.7 0.0

Hattori et al., 2016 (95) Japanese 2774 Men and women 81.8 17.4 0.8

Adams et al., 2015 (104) US 170 Premenopausal women 88.0 12.0 0.0
151 Men and women 84.0 15.0 1.0

130 Men and women with SIP 75.4 23.8 0.8
Starska et al., 2015 (80) Polish 418 Control men and women without head or neck tumour 95.5 4.1 0.0

117 Men and women with SIP 76.1 23.1 0.8
Starska et al., 2015 (84) Polish 132 Control men and women with normal sinonasal mucosa 87.9 12.1 0.0

323 Men and women with SCC 89.2 9.9 0.9
Starska et al., 2014 (85) Polish 116 Control men and women with normal laryngeal mucosa 84.5 14.6 0.9

323 Men and women with laryngeal cancer 89.2 9.9 0.9
Starska et al., 2014 (81) Polish 418 Control healthy men and women 84.0 16.0 0.0

Krześlak et al., 2014 (82) 534 Women with ductal breast cancer 87.1 12.3 0.6
Polish 556 Control healthy women 92.8 7.2 0.0

Krześlak et al., 2013 (86) 412 Men with prostate cancer 76.0 21.1 2.9
Polish 67 Control men without prostate cancer 88.0 12.0 0.0

Wang et al., 2012 (106) US 239 Men and women 89.1 10.1 0.8

358 Men with prostate cancer 76.8 20.9 2.3
Forma et al., 2012 (87) Polish 406 Control men without prostate cancer 88.9 10.6 0.5

Tekin et al., 2012 (89) Turkish 95 Mother-newborn pairs 87.4 12.6 0.0

Tekin et al., 2012 (90) Turkish 91 Mother-newborn pairs 86.8 13.2 0.0

Kayaalti et al., 2011 (91) Turkish 616 Men and women 86.6 12.8 0.6

Kayaalti et al., 2011 (92) Turkish 354 Men and women 90.4 9.0 0.6

McElroy et al., 2010 (98) US 142 Black women 97.9 2.1 -
149 White women 87.3 12.8 -

Kayaalti et al., 2010 (93) Turkish 122 Men and women (kidney samples) 88.5 10.7 0.8
186 Men and women (blood samples) 86.0 13.4 0.6

Kayaalti et al., 2010 (94) Turkish 114 Men and women (kidney samples) 87.7 11.4 0.9

Hayashi et al., 2006 (96) 37 Patients with SALS 75.7 24.3 0.0
Japanese 206 Control healthy men and women 82.5 17.0 0.5

Association between the rs10636 (MT2A +838G/O sinslenucleotide nolvmornhism and element concentrations in humans

Authors and year of publication (reference No.) Ethnicity n Study participants Sample type MT2A genotype
Findings
GG GC CC

Cd concentrations (μg/L)
Adams et al., 2015 (104) US 321 Men and women Urine (Graphical illustration) ↓Cd in urine of C allele carriers

Chen et al, 2012 (118) Chinese 311 Women exposed to Cd Blood/ Urine (Graphical illustration) Trends of ↓Cd in blood of C allele carriers in highly polluted area; no difference of Cd in urine
Pb concentrations (μg/L)
Yang et al., 2017 (105) Thai 677 Men and women Whole blood 116±119 121±121 124±141 No difference between genotypes

Fernandes et al, 2016(119) Brazilian 221 Workers in car battery factories Whole blood (Graphical illustration) C allele carriers ↓Pb in blood

Gundacker et al., 2009 (120) Austrian 122 Men and women Whole blood 20.2 21.3 16.9 CC genotype had ↓ Pb in blood
Hg concentrations (μg/Lor μg/kg*)
Woods et al, 2013(116) Portuguese 96 Boys of avg. age 10 years Urine 2.17±2.15 2.16±2.16§ No difference between genotypes

Wang et al., 2012 (106) US 464 Men and women Urine 1.04 1.04 1.22 No difference between genotypes

473 Men and women Hair 500* 430* 570*
Fe concentrations (mg/L)
Giacconi et al., 2007(113) Italian 288 CS patients Plasma 1.11±0.47 0.99±0.32§ C allele carriers had ↓Fe in plasma

Erythrocytes 505±270 506±102§
Zn concentrations (mg/L)
Adams et al, 2015 (104) US 321 Men and women Urine (Graphical illustration) ↓Zn in urine of C allele carriers

Giacconi et al, 2007 (113) Italian 288 Patients with CS Plasma 0.71±0.17 0.74±0.15§ C allele carriers ↑Zn in erythrocytes
Erythrocytes 7.4±2.6 8.5±2.0§
Cu concentrations (mg/L)
Adams et al, 2015 (104) US 321 Men and women Urine (Graphical illustration) ↓Cu in urine of C allele carriers

Giacconi et al, 2007 (113) Italian 288 Patients with CS Plasma 1.07±0.29 l.ll±0.24§ C allele carriers ↑Cu in erythrocytes
Erythrocytes 0.52±0.11 0.56±0.13§
eISSN:
1848-6312
Langues:
Anglais, Slovenian
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Basic Medical Science, other